AG
GILD icon

AlTi Global’s Gilead Sciences GILD Stock Holding History

AlTi Global’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,298
Closed -$477K – 462
2025
Q3 		$477K Buy
4,298
+158
+4% +$18K 0.01% 318
2025
Q2 		$459K Buy
4,140
+446
+12% +$47.5K 0.01% 310
2025
Q1 		$413K Sell
3,694
-110
-3% -$11.3K 0.01% 292
2024
Q4 		$351K Buy
3,804
+16
+0.4% +$1.44K 0.01% 326
2024
Q3 		$318K Buy
+3,788
New +$289K 0.01% 315

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AlTi Global's GILD Position: Q4 2025 in Review

AlTi Global sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 4,298 shares — an estimated $477K sold.

AlTi Global first reported a position in GILD in Q3 2024 and held it in 5 quarters. The position peaked at $477K in Q3 2025. 2,217 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • AlTi Global reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • AlTi Global sold 4,298 Gilead Sciences shares in Q4 2025, an estimated $477K.
  • AlTi Global first reported a position in Gilead Sciences in Q3 2024 and held it in 5 quarters.
  • AlTi Global's Gilead Sciences position peaked at $477K in Q3 2025.
  • 2,217 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on AlTi Global's 13F filing for Q4 2025, filed 13 Feb 2026.